Nov, 2019 Pharma & Healthcare
Global Cardiac Monitoring Market Analysis 2019 - Projections Report 2026
Category by- Pharma & Healthcare , No. of Pages - 91, Published By - QYR
Cardiac monitoring generally refers to continuous or intermittent monitoring of heart activity, generally by electrocardiography, with assessment of the patient's condition relative to their cardiac rhythm. It is different from hemodynamic monitoring, which monitors the pressure and flow of blood within the cardiovascular system. The two may be performed simultaneously on critical heart patients. Cardiac monitoring with a small device worn by an ambulatory patient is known as ambulatory electrocardiography. Transmitting data from a monitor to a distant monitoring station is known as telemetry or biotelemetry.
Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major concern in most parts of the world. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of more than 370,000 people annually. The American Heart Association (AHA) reports cardiovascular disease to be the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. The Heart Foundation also states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2014. The other factors boosting the growth of the market studied are - technological advancements, patient awareness, and the increasing number of unmet medical needs in developing and underdeveloped countries.
The Americas witness an increase in the prevalence of CVDs mainly due to the unhealthy lifestyle of the residents. The international vendors such as GE Healthcare and Abbott operate in this region and offer technologically advanced products. US will be the major revenue contributor to the heart monitoring device market.
The global Cardiac Monitoring market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cardiac Monitoring volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiac Monitoring market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abbott
GE Healthcare
Hill-Rom
Medtronic
Philips Healthcare
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Electrocardiogram (ECG) Devices
Implantable Loop Recorder (ILRs)
Cardiac Event Monitors
Cardiac Output Monitoring (COM) Devices
Segment by Application
Home and Ambulatory
Hospital
Cardiovascular diseases have become one of the primary reasons for mortality and are becoming a major concern in most parts of the world. Coronary heart disease (CHD) is the most common type of heart disease, with a death toll of more than 370,000 people annually. The American Heart Association (AHA) reports cardiovascular disease to be the leading global cause of death, accounting for 17.3 million deaths per year, a number that is expected to grow to more than 23.6 million by 2030. The Heart Foundation also states that CVD is a major cause of death in Australia, with 45,053 deaths attributed to CVD in the country, in 2014. The other factors boosting the growth of the market studied are - technological advancements, patient awareness, and the increasing number of unmet medical needs in developing and underdeveloped countries.
The Americas witness an increase in the prevalence of CVDs mainly due to the unhealthy lifestyle of the residents. The international vendors such as GE Healthcare and Abbott operate in this region and offer technologically advanced products. US will be the major revenue contributor to the heart monitoring device market.
The global Cardiac Monitoring market is valued at xx million US$ in 2018 is expected to reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cardiac Monitoring volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiac Monitoring market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Abbott
GE Healthcare
Hill-Rom
Medtronic
Philips Healthcare
...
Segment by Regions
North America
Europe
China
Japan
Segment by Type
Electrocardiogram (ECG) Devices
Implantable Loop Recorder (ILRs)
Cardiac Event Monitors
Cardiac Output Monitoring (COM) Devices
Segment by Application
Home and Ambulatory
Hospital